Villanueva ELA, Pichardo CM

Language: Spanish
References: 23
Page: 35-42
PDF size: 159.44 Kb.

ABSTRACT

This review provides an update regarding newer options in hormonal contraception that include the progestin-releasing intrauterine system, the contraceptive patch and ring, the single rod progestin-releasing implant, extended and emergency oral contraception and recent advances in hormonal male contraception. These methods represent a major advancement in this field, allowing for the development of more acceptable, safety and effective birth control regimens.

REFERENCES

1. Chadha P, Friedman AJ. An industry perspective on the evolution of hormonal contraceptive development. Fertil Steril 2004;2:119-24.

2. Calaf J, Espinos JJ. Anticoncepción hormonal oral. En: Vanrell JA, Calaf J, Balasch J, Viscasillas P, editores. Fertilidad y esterilidad humana. Endocrinología ginecológica y anticoncepción (TII). 2a ed. Barcelona: Masson, 2000;pp:357-69.

3. Hussar DA. New drugs of 2001. J Am Pharm Assoc 2002;42:227-66.

4. Archer DF. New contraceptive options. Clin Obstet Gynecol 2001;44:122-6.

5. Rosenberg MJ, Meyers A, Roy V. Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations. Contraception 2000;60:321-9.

6. Thorneycroft IH. Cycle control with oral contraceptives: a review of the literature. Am J Obstet Gynecol 1999;180:S280-7.

7. Miller L, Notter KM. Menstrual reduction with extended use of combination oral contraceptive pills: randomized controlled trial. Obstet Gynecol 2001;98:771-8.

8. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003;68:89-96.

9. Kuohong W, Borgatta L, Stubblefield P. Low-dose oral contraceptives and bone mineral density: an evidence-based analysis. Contraception 2000;61:77-82.

10. Burkman R, Schlesselman JJ, Zieman M. Safety concerns and health benefits associated with oral contraception. Am J Obstet Gynecol 2004;190:S5-22.

11. Morales del Olmo A, Vega A, Fuentes SG, Pérez PG. Anticoncepción postaborto. Ginec Obstet Méx 1997;66:65-8.

12. Schiavon-Ermani R. Anticoncepción de emergencia: de viejo secreto a derecho sexual y reproductivo. Perinatol Reprod Hum 2003;17:245-54.

13. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 69. Emergency contraception. Obstet Gynecol 2005;106:1443-52.

14. Croxatto HB, Ortiz ME, Muller AL. Mechanisms of action of emergency contraception. Steroids 2003;68:1095-8.

15. Kaunitz AM. Beyond the pill: new data and options in hormonal and intrauterine contraception. Am J Obstet Gynecol 2005;192:998-1004

16. Alexander NJ. New methods of delivering hormonal contraception. Contemporary Ob Gyn 2002;4:44-52.

17. Dieben T, Roumen FJ, Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585-93.

18. Croxatto HB. Progestin implants for female contraception. Contraception 2002;65:15-9.

19. Glassier A. Implantable contraceptive for women effectiveness, discontinuation rates, return of fertility and outcome of pregnancies. Contraception 2002;65:29-37.

20. Kamischke A, Nieschlag E. Progress towards hormonal male contraception. Trends Pharmacol Sci 2004;25:49-57.

21. Brady BM, Amory JK, Perheentupa A, Zitzmann M, et al. A multicentre study investigating subcutaneous etonogestrel implants with injectable testosterone decanoate as a potential long-acting male contraceptive. Human Reproduction 2006;21:285-94.

22. Federación Internacional de Planificación de la Familia. IPPF Carta sobre los derechos sexuales y reproductivos. 1996. Londres, IPPF.

23. Federación Latinoamericana de Sociedades de Obstetricia y Ginecología (FLASOG). Derechos sexuales y reproductivos. Santa Cruz de la Sierra, Bolivia19 de octubre del 2002.